Imagen de portada del programa GEN Podcasts

GEN Podcasts

Podcast de Genetic Engineering & Biotechnology News (GEN)

inglés

Tecnología y ciencia

Empieza 7 días de prueba

$99 / mes después de la prueba.Cancela cuando quieras.

  • 20 horas de audiolibros al mes
  • Podcasts solo en Podimo
  • Podcast gratuitos
Prueba gratis

Acerca de GEN Podcasts

Genetic Engineering & Biotechnology News (GEN) has retained its position as the premier biotech publication since its launch in 1981. GEN publishes a print edition monthly and has additional exclusive editorial content online, including news and analysis as well as webinars, videos, and polls. GEN's unique news and technology focus covers the entire bioproduct life cycle, including drug discovery, early-stage R&D, applied research (e.g., omics, biomarkers, and diagnostics), bioprocessing, and commercialization.GEN's print magazine, which also can easily be accessed online, includes feature articles on emerging technologies, product roundups, in-depth overviews from key scientific and bioindustry meetings, and industry-standard tutorials and technical articles on drug discovery, bioprocessing, and assay technologies. Hosted on Acast. See acast.com/privacy for more information.

Todos los episodios

8 episodios

episode Enabling In Vivo Lentiviral Therapies: Manufacturing Strategies to Improve Purity, Scalability, and Clinical Readiness. artwork

Enabling In Vivo Lentiviral Therapies: Manufacturing Strategies to Improve Purity, Scalability, and Clinical Readiness.

Lentiviral vectors are gaining momentum not just as ex vivo tools but as potential in vivo therapeutic platforms. But with that shift comes a number of manufacturing challenges, including higher doses, tighter control of impurities, greater batch consistency, and scalable processes to meet both clinical and commercial needs. In this GEN Podcast, two experts from SK Pharmteco, a global CMO, address these challenges and lay out some best practices that guide the manufacture of lentiviral vectors with the requisite purity, robustness, and economic feasibility required for widespread clinical adoption. Guest speakers: Mardhani Aparajithan, Director of Manufacturing, Science and Technology, SK Pharmteco Tatiana Nanda, PhD, CTO, Cell and Gene Therapy, SK Pharmteco Moderator: Kevin Davies, PhD, Editorial Director, GEN ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

21 de abr de 2026 - 35 min
episode The Future of Bioinformatics: Scaling Interactive and Computational Workflows with Seqera artwork

The Future of Bioinformatics: Scaling Interactive and Computational Workflows with Seqera

Sponsored by Seqera As data volumes in life sciences continue to grow, bioinformaticians and researchers are more dependent than ever on solutions that help them streamline workflows, manage data, and scale their research. In this timely podcast, Evan Floden, CEO and co-founder of Seqera, shares how his company is addressing these needs through Nextflow—the open-source orchestrator for scalable, reproducible, and portable scientific workflows—and Seqera Platform, a unified solution for the entire scientific data lifecycle. He also discusses how Seqera has become a widely adopted solution, trusted by 13 of the top 20 pharmaceutical companies, empowering breakthroughs in drug discovery, genomics, clinical research, and.beyond. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

11 de abr de 2025 - 18 min
episode From Functional Genomics to Cell Therapy: The Role of CRISPR-based Gene Editing artwork

From Functional Genomics to Cell Therapy: The Role of CRISPR-based Gene Editing

There are an estimated 6,000 Mendelian diseases, most of which still lack cures. Gene editing is an essential technology for studies aimed at generating data about disease-causing gene mutations and networks in order to identify optimal therapeutic targets. In this episode, experts will discuss applications of gene editing to improve scientists understanding of the relationship between variant and disease in functional genomics studies. They will also talk about the Dharmacon product suite which is designed for CRISPR-based targeted editing in a wide range of cells. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

8 de abr de 2025 - 58 min
episode Precision Base Editing Meets Single-Cell Multiomics to Advance Cell and Gene Therapies artwork

Precision Base Editing Meets Single-Cell Multiomics to Advance Cell and Gene Therapies

In this episode, you’ll hear a group of experts discussing base editing and how the technology is helping scientists engineer powerful cell therapies for various diseases including novel CAR-T therapies and hypoimmunogenic induced pluripotent stem cells. During the discussion, they will cover the merits of the Pin-point base editing platform, which introduces gene modifications without relying on double-strand DNA breaks, as well as how TotalSeq reagents, which confirm the safety and efficiency of editing with the Pin-point platform, support single cell multiomics analysis of edited cells. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

28 de mar de 2025 - 33 min
Muy buenos Podcasts , entretenido y con historias educativas y divertidas depende de lo que cada uno busque. Yo lo suelo usar en el trabajo ya que estoy muchas horas y necesito cancelar el ruido de al rededor , Auriculares y a disfrutar ..!!
Muy buenos Podcasts , entretenido y con historias educativas y divertidas depende de lo que cada uno busque. Yo lo suelo usar en el trabajo ya que estoy muchas horas y necesito cancelar el ruido de al rededor , Auriculares y a disfrutar ..!!
Fantástica aplicación. Yo solo uso los podcast. Por un precio módico los tienes variados y cada vez más.
Me encanta la app, concentra los mejores podcast y bueno ya era ora de pagarles a todos estos creadores de contenido

Elige tu suscripción

Más populares

Premium

20 horas de audiolibros

  • Podcasts solo en Podimo

  • Disfruta los shows de Podimo sin anuncios

  • Cancela cuando quieras

Empieza 7 días de prueba
Después $99 / mes

Prueba gratis

Sólo en Podimo

Audiolibros populares

Prueba gratis

Empieza 7 días de prueba. $99 / mes después de la prueba. Cancela cuando quieras.